Skip to main content

Table 4 Comorbidities seen in COVID-19 patients

From: Olfactory dysfunction as a screening tool for mild and moderate cases of COVID-19: a single-center prevalence study of 646 patients in flu clinic

Co-morbidity

N (%)

 No

483 (74.8)

 Hypertension

89 (13.8)

 Diabetes

40 (6.2)

 Thyroid

22 (3.4)

 Coronary artery disease

9 (1.4)

 Tuberculosis

7 (1.1)

 Asthma

7 (1.1)

 Chronic kidney disease

4 (0.6)

 Autoimmune

5 (0.8)

 COPD

4 (0.6)

 Carcinoma

3 (0.5)